No images? Click here
2 April 2025
Last year, the Global Malaria Programme (GMP) unveiled a new operational strategy outlining its technical direction for the period 2024–2030. The Programme’s 2024 annual report, released this week, highlights progress in driving malaria responses forward through the strategy’s four key levers: technical leadership, norms and standards, new tools and innovation, and strategic information for impact.
Uganda’s Ministry of Health introduced malaria vaccines today into its routine immunization programme – the largest country rollout to date, benefiting children in 105 moderate and high transmission districts. With this announcement and Burundi’s introduction in March, a total of 19 countries are now providing WHO-recommended malaria vaccines. Their widescale deployment in Africa is expected to save tens of thousands of young live.
Uganda press release | Burundi press release | Q&A: RTS,S, and R21
As World Malaria Day approaches on 25 April, WHO, alongside the RBM Partnership and other partners, is rallying support for this year’s theme: “Malaria Ends With Us: Reinvest, Reimagine, Reignite”. Ending malaria is not just a health priority – it is an investment in a safer and more equitable world. The choice is ours: act now or risk losing ground.
Expanding online learning to strengthen malaria responses
The Global Malaria Programme is scaling up efforts to provide accessible, high-quality malaria training through online learning platforms. In June 2022, the Programme released a 13-module “Malaria elimination” curriculum on the OpenWHO platform. This course transitioned to the WHO Academy platform in 2024, with an updated version planned for 2025 to ensure frontline health providers have access to the latest guidance and best practices. Building on this effort, the Programme partnered with the WHO Academy to introduce “Malaria: harnessing the power of routine facility data,” a self-paced course that equips health professionals with the skills to analyze and interpret routine malaria surveillance data.
Malaria elimination | Malaria: harnessing the power of routine facility data
Latest meeting reports
- Quality of conduct and interpretation of insecticide susceptibility in bioassays using new insecticides for vector control
- Regional stakeholder meeting on the response to antimalarial drug resistance in Africa
- Subregional networks of antimalaria drug efficacy and resistance in Eastern Africa and Horn of Africa countries
- Extending the WHO scheme for external quality assessment of nucleic acid amplification testing for monitoring antimalarial drug resistance
